AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitoha M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Orris Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitoha M 50mg/1000mg Tablet

Combiflora 50mg/1000mg tablets combine two active ingredients to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications, such as vision impairment and renal dysfunction, and may lessen the risk of cardiovascular events. Combiflora 50mg/1000mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved with a healthy lifestyle, including diet and exercise. Dosage is individualized based on your medical history, blood sugar readings, and concurrent medications. Ingesting the tablets with food can minimize gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician supervision. Adherence to your prescribed diet and exercise plan is crucial. Your lifestyle choices significantly impact diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, requires awareness and prompt management. This medication is not universally suitable. Prior to commencement, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel. Potential drug interactions necessitate disclosure of all other medications to your doctor. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Primary Ingredients of Sitoha M 50mg/1000mg Tablet

No information provided. Please provide the text you wish to be rephrased.

Uses of Sitoha M 50mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Sitoha M 50mg/1000mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Sitoha M 50mg/1000mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

Common Side effects of Sitoha M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitoha M 50mg/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Sitoha M 50mg/1000mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitoha M 50mg/1000mg Tablet works:

Each Sitoha M 50mg/1000mg tablet unites sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitoha M 50mg/1000mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitoha M 50mg/1000mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against the risks prior to prescribing. Consult your physician for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Sitoha M 50mg/1000mg tablets is likely inadvisable. Available data from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitoha M 50mg/1000mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitoha M 50mg/1000mg tablets. Physician consultation is essential. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Sitoha M 50mg/1000mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitoha M 50mg/1000mg Tablet :

Should you forget to take your Sitoha M 50mg/1000mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Sitoha M 50mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitoha M 50mg/1000mg Tablet

Sitoha M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitoha M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitoha M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitoha M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitoha M 50mg/1000mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin (like Sitoha M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Sitoha M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitoha M 50mg/1000mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Sitoha M 50mg/1000mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitoha M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/1000mg can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitoha M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitoha M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitoha M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitoha M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitoha M 50mg/1000mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/1000mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue the medication and seek immediate medical attention.
Prolonged use of Sitoha M 50mg/1000mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance issues), urinary problems, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitoha M 50mg/1000mg Tabl...
194